Drug Safety

The ISoP Bengt-Erik Wiholm Memorial Lecture
pp. 181-185(5)
Author: Edwards, I. Ralph

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive
pp. 187-202(16)
Authors: Dormandy, John; Bhattacharya, Mondira; >Anne-Ruth van Troostenburg de Bruyn,

Reducing Harm Associated with Anticoagulation: Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia
pp. 203-218(16)
Authors: Hursting, Marcie J.; Soffer, Joseph

Bisphosphonates and Atrial Fibrillation: Systematic Review and Meta-Analysis
pp. 219-228(10)
Authors: >Yoon Kong Loke,; Jeevanantham, Vinodh; Singh, Sonal

Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK: An Observational Study
pp. 229-237(9)
Authors: Fogg, Carole; Kasliwal, Rachna; Shakir, Saad A.W.

First-Trimester Itraconazole Exposure and Pregnancy Outcome: A Prospective Cohort Study of Women Contacting Teratology Information Services in Italy
pp. 239-244(6)
Authors: >Marco De Santis,; >Elena Di Gianantonio,; Cesari, Elena; Ambrosini, Guido; Straface, Gianluca; Clementi, Maurizio

Drug Safety Information Through the Internet: The Experience of an Italian Website
pp. 245-253(9)
Authors: Polimeni, Giovanni; Russo, Alessandra; >Maria Antonietta Catania,; Aiello, Andrea; Oteri, Alessandro; Trifirò, Gianluca; Calapai, Gioacchino; Sautebin, Lidia; Iacobelli, Massimo; Caputi, Achille P.

Spontaneous ADR Reports as a Trigger for Pharmacogenetic Research: A Prospective Observational Study in the Netherlands
pp. 255-264(10)
Authors: >Eugène van Puijenbroek,; Conemans, Jean; >Kees van Grootheest,

Pharmacogenetics and Pharmacovigilance
pp. 265-270(6)
Author: Howland, Robert H.